Literature DB >> 29380057

Commentary on: Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries.

Juste Aristide Goungounga1, Roch Giorgi2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29380057     DOI： 10.1007/s00432-017-2559-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  5 in total

1.  Adjusting for age-related competing mortality in long-term cancer clinical trials.

Authors:  B Cheuvart; L Ryan
Journal:  Stat Med       Date:  1991-01       Impact factor: 2.373

2.  On estimation in relative survival.

Authors:  Maja Pohar Perme; Janez Stare; Jacques Estève
Journal:  Biometrics       Date:  2011-06-20       Impact factor: 2.571

3.  Challenges in the estimation of Net SURvival: The CENSUR working survival group.

Authors:  R Giorgi
Journal:  Rev Epidemiol Sante Publique       Date:  2016-10-25       Impact factor: 1.019

4.  The impact of additional life-table variables on excess mortality estimates.

Authors:  Nathalie Grafféo; Valérie Jooste; Roch Giorgi
Journal:  Stat Med       Date:  2012-07-17       Impact factor: 2.373

5.  Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries.

Authors:  Alix Augustin; Steven Le Gouill; Rémy Gressin; Aurélie Bertaut; Alain Monnereau; Anne-Sophie Woronoff; Brigitte Trétarre; Patricia Delafosse; Xavier Troussard; Anne Moreau; Olivier Hermine; Marc Maynadié
Journal:  J Cancer Res Clin Oncol       Date:  2017-10-11       Impact factor: 4.553
  5 in total
  1 in total

1.  Correcting for misclassification and selection effects in estimating net survival in clinical trials.

Authors:  Juste Aristide Goungounga; Célia Touraine; Nathalie Grafféo; Roch Giorgi
Journal:  BMC Med Res Methodol       Date:  2019-05-16       Impact factor: 4.615
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.